Zhao, S., Wu, W., Jiang, H., Ma, L., Pan, C., Jin, C., . . . Wang, K. (2021). Selective Inhibitor of the c-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib? Frontiers Media S.A.
Style de citation Chicago (17e éd.)Zhao, Shankun, Weizhou Wu, Hao Jiang, Lei Ma, Chengyi Pan, Chong Jin, Jinggang Mo, Liezhi Wang, et Kunpeng Wang. Selective Inhibitor of the C-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib? Frontiers Media S.A, 2021.
Style de citation MLA (8e éd.)Zhao, Shankun, et al. Selective Inhibitor of the C-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib? Frontiers Media S.A, 2021.